TAXOL

This brand name is authorized in Brazil, Hong Kong SAR China, Japan, Singapore, South Africa.

Active ingredients

The drug TAXOL contains one active pharmaceutical ingredient (API):

1	Paclitaxel UNII P88XT4IS4D - PACLITAXEL
	Paclitaxel is an antimicrotubule agent that promotes the assembly of microtubules from tubulin dimers and stabilises microtubules by preventing depolymerisation. This stability results in the inhibition of the normal dynamic reorganisation of the microtubule network that is essential for vital interphase and mitotic cellular functions.
	Read more about Paclitaxel

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L01CD01	Paclitaxel	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01C Plant alkaloids and other natural products → L01CD Taxanes
Discover more medicines within L01CD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	505105901159312, 505105902155310, 505105903151319
HK	Department of Health Drug Office	37867
JP	医薬品医療機器総合機構	4240406A1031, 4240406A2038
SG	Health Sciences Authority	07616P
ZA	Health Products Regulatory Authority	28/26/0157, 31/26/0107, 35/26/0196